Literature DB >> 30674373

Xpert at 8 years: where are we now, and what should we do next?

D W Dowdy.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30674373      PMCID： PMC7804517          DOI： 10.5588/ijtld.18.0717

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  3 in total

1.  Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.

Authors:  T Agizew; R Boyd; A F Auld; L Payton; S L Pals; P Lekone; V Chihota; A Finlay
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

2.  Screening for Tuberculosis With Xpert MTB/RIF Assay Versus Fluorescent Microscopy Among Adults Newly Diagnosed With Human Immunodeficiency Virus in Rural Malawi: A Cluster Randomized Trial (Chepetsa).

Authors:  Lucky G Ngwira; Elizabeth L Corbett; McEwen Khundi; Grace L Barnes; Austin Nkhoma; Michael Murowa; Silvia Cohn; Lawrence H Moulton; Richard E Chaisson; David W Dowdy
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

Review 3.  Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

Authors:  Heidi Albert; Ruvandhi R Nathavitharana; Chris Isaacs; Madhukar Pai; Claudia M Denkinger; Catharina C Boehme
Journal:  Eur Respir J       Date:  2016-07-13       Impact factor: 16.671
  3 in total
  2 in total

1.  Improving the design of studies evaluating the impact of diagnostic tests for tuberculosis on health outcomes: a qualitative study of perspectives of diverse stakeholders.

Authors:  Eleanor A Ochodo; Selvan Naidoo; Samuel Schumacher; Karen Steingart; Jon Deeks; Frank Cobelens; Patrick M Bossuyt; Taryn Young; Mark P Nicol
Journal:  Wellcome Open Res       Date:  2019-11-21

2.  Ensuring that Xpert® MTB/RIF is used to its maximum potential.

Authors:  A D Harries; C Timire; K C Takarinda; C Sandy
Journal:  Int J Tuberc Lung Dis       Date:  2019-09-01       Impact factor: 2.373
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.